about
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsProduction of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiotaAntibiotic resistance in Prevotella species isolated from patients with cystic fibrosisFosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.Evidence of persistence of Prevotella spp. in the cystic fibrosis lung.Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3-week-old piglets.Corrigendum to 'Efficacy of a standard meticillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice' [Journal of Hospital Infection (2010) 93-98].In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system.T lymphocyte epitope mapping of porcine circovirus type 2.Evaluation of a porcine circovirus type 2-specific antigen-capture enzyme-linked immunosorbent assay for the diagnosis of postweaning multisystemic wasting syndrome in pigs: comparison with virus isolation, immunohistochemistry, and the polymerase cAntimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys.Criteria required for an acceptable point-of-care test for UTI detection: Obtaining consensus using the Delphi technique.Dual functional ionic liquids as antimicrobials and plasticisers for medical grade PVCsChanges in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia)Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patientsThe airway microbiome in cystic fibrosis: challenges for therapyUse of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosisDetection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic FibrosisCluster randomised controlled trial of an infection control education and training intervention programme focusing on meticillin-resistant Staphylococcus aureus in nursing homes for older peopleEfficacy of a standard meticillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practicePrevalence of Methicillin-Resistant Staphylococcus aureus Colonization in Residents and Staff in Nursing Homes in Northern IrelandIn vitro activity of tea-tree oil against clinical skin isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilmsRapid detection of MRSA in a routine diagnostic laboratory using a real-time PCR assayTreatment of a cochlear implant biofilm infection: a potential role for alternative antimicrobial agentsInfection control and meticillin-resistant Staphylococcus aureus decolonization: the perspective of nursing home staff"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisActivity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputumElectronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens
P50
Q34180324-47924D09-3921-4748-896B-0E93A8D7FD2BQ34181466-9B593DEF-FF3C-47A9-BD5A-07ACD2543E8DQ34437958-DB95DD95-FDD1-4287-AE13-61EABA03B337Q36558320-6A4B1246-C66C-48D8-BB1F-A9C0EAC3B8DCQ37169933-8667E7CA-F175-408E-84BB-1FD89AA2C6CCQ37263313-4F953A24-DF3D-45E4-970D-E8C415828415Q38130513-4BB34215-E409-43D3-8AB9-40866619941BQ40163854-1A6D7975-A6F4-48EC-BF3A-754BE4B34ADCQ40229905-4F1EF1BF-F65D-4A5F-A398-68166611608BQ40475321-D2FCBD6D-E3C3-4CB5-B044-6EE99D9670D7Q40490627-6807365B-7027-4BEB-8801-F7F2059AC678Q43779831-AA95F938-60B5-40D9-960A-9B7326BAAA2CQ44173154-CFDE92B1-56DD-4245-ABC2-053D0DBCA96EQ45733004-8D9E1CD0-7EB0-481C-A4C3-D14084D796A9Q46866147-2E5C3FE8-B8BB-484F-B04E-0CA69BD33A6BQ55349691-DD11F6BF-0F6B-4B01-ABD3-1AC272863666Q57086988-6148710B-1DE1-432A-AB05-D892967155AAQ57719392-521B9C09-D893-407C-BBCB-DA1CBC46FB97Q57787802-8C69AA6F-B816-47E6-B34A-6FA7F791FF9BQ57913623-15446283-BCB5-443D-9600-8522338AC731Q57913629-3E0D12BA-F3A6-49DE-BE37-B78C85C9EB7CQ57913654-30F9B912-D0B5-4243-9DA2-656FDDB3FBCBQ58967736-C8A30D52-058C-43EB-80E5-896F5AC40BB0Q58967888-32CA731C-5031-4A87-94AB-C5D09C232727Q58968130-D3A27982-6905-4ACC-8C2E-96A70BBB702CQ79149629-1FB315B0-A86A-4EF4-89AE-4418EAA0F670Q80844255-D5C75998-CE3E-4C0A-91BB-C9F842C96AD6Q83160222-494681D9-87CF-4015-99CF-84FAF9C8C135Q84444536-C52282CC-3689-4345-8481-B06D66CAC2CBQ89013298-112E0117-0DD5-473F-BD3F-28E630FAE146Q91467821-89B8F3C3-043D-4AD5-9B04-996305E40C97Q92055044-3A4839E3-5B75-44F4-938E-FF35EEA1F0E9
P50
description
researcher ORCID ID = 0000-0001-6617-233X
@en
wetenschapper
@nl
name
Deirdre F Gilpin
@ast
Deirdre F Gilpin
@en
Deirdre F Gilpin
@es
Deirdre F Gilpin
@nl
type
label
Deirdre F Gilpin
@ast
Deirdre F Gilpin
@en
Deirdre F Gilpin
@es
Deirdre F Gilpin
@nl
prefLabel
Deirdre F Gilpin
@ast
Deirdre F Gilpin
@en
Deirdre F Gilpin
@es
Deirdre F Gilpin
@nl
P1153
6603712534
P31
P496
0000-0001-6617-233X